Thailand’s cannabis policy has entered a new phase in 2026, as the government advances regulatory reforms aimed at clarifying medical use, strengthening oversight and addressing concerns that emerged following the country’s landmark decriminalisation.

After becoming the first nation in Asia to remove cannabis from its narcotics list in 2022, Thailand witnessed a rapid proliferation of dispensaries, cultivation operations and cannabis-infused products.

The liberalisation was initially framed as an economic opportunity for farmers and entrepreneurs, with officials promoting the plant’s medical and commercial potential.

However, the speed of expansion prompted growing calls for clearer rules, particularly around recreational consumption, youth access and public health standards.

Policymakers have since sought to recalibrate the framework, emphasising that cannabis use should be primarily medical and research-oriented rather than recreational.

In 2026, draft legislation and ministerial regulations have focused on licensing requirements, zoning restrictions and prescription-based access.

Authorities are working to tighten controls on advertising and product labelling, while introducing clearer penalties for unauthorised sales.

The government has stressed that the reforms are intended to protect public health without reversing the broader economic benefits generated by the sector.

Health officials have pointed to the need for consistent quality control and medical supervision, citing cases in which unclear dosing or unregulated products led to public concern.

At the same time, agricultural groups have urged regulators to preserve pathways that allow small-scale growers to participate in the legal market.

The policy recalibration reflects a broader debate within Thai society over balancing innovation with oversight.

While some stakeholders argue that stricter controls could dampen investment, others contend that regulatory clarity will strengthen the industry’s credibility and attract more sustainable capital.

As the legal landscape evolves, Thailand remains at the forefront of cannabis reform in Asia, navigating the complex transition from rapid liberalisation to a more structured, health-centred regulatory model.